317 related articles for article (PubMed ID: 3319729)
1. Hair follicle biology and topical minoxidil: possible mechanisms of action.
Headington JT
Dermatologica; 1987; 175 Suppl 2():19-22. PubMed ID: 3319729
[TBL] [Abstract][Full Text] [Related]
2. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
Barbareschi M
G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
[TBL] [Abstract][Full Text] [Related]
3. [Hair growth effect of minoxidil].
Otomo S
Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):167-74. PubMed ID: 11915519
[TBL] [Abstract][Full Text] [Related]
4. Topical minoxidil therapy for hair regrowth.
Rumsfield JA; West DP; Fiedler-Weiss VC
Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
[TBL] [Abstract][Full Text] [Related]
5. Minoxidil: mechanisms of action on hair growth.
Messenger AG; Rundegren J
Br J Dermatol; 2004 Feb; 150(2):186-94. PubMed ID: 14996087
[TBL] [Abstract][Full Text] [Related]
6. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle.
Han JH; Kwon OS; Chung JH; Cho KH; Eun HC; Kim KH
J Dermatol Sci; 2004 Apr; 34(2):91-8. PubMed ID: 15033191
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypertrichotic agents on follicular and nonfollicular cells in vitro.
Kurata S; Uno H; Allen-Hoffmann BL
Skin Pharmacol; 1996; 9(1):3-8. PubMed ID: 8868027
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
Meephansan J; Thummakriengkrai J; Ponnikorn S; Yingmema W; Deenonpoe R; Suchonwanit P
Arch Dermatol Res; 2017 Nov; 309(9):729-738. PubMed ID: 28884378
[TBL] [Abstract][Full Text] [Related]
9. Preparation of topical bimatoprost with enhanced skin infiltration and
Subedi L; Pandey P; Shim JH; Kim KT; Cho SS; Koo KT; Kim BJ; Park JW
Drug Deliv; 2022 Dec; 29(1):328-341. PubMed ID: 35040730
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.
Goren A; Naccarato T; Situm M; Kovacevic M; Lotti T; McCoy J
J Biol Regul Homeost Agents; 2017; 31(4):1049-1053. PubMed ID: 29254313
[TBL] [Abstract][Full Text] [Related]
11. Minoxidil activates β-catenin pathway in human dermal papilla cells: a possible explanation for its anagen prolongation effect.
Kwack MH; Kang BM; Kim MK; Kim JC; Sung YK
J Dermatol Sci; 2011 Jun; 62(3):154-9. PubMed ID: 21524889
[TBL] [Abstract][Full Text] [Related]
12. Minoxidil use in dermatology, side effects and recent patents.
Rossi A; Cantisani C; Melis L; Iorio A; Scali E; Calvieri S
Recent Pat Inflamm Allergy Drug Discov; 2012 May; 6(2):130-6. PubMed ID: 22409453
[TBL] [Abstract][Full Text] [Related]
13. The penetration enhancer SEPA augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque.
Diani AR; Shull KL; Zaya MJ; Brunden MN
Skin Pharmacol; 1995; 8(5):221-8. PubMed ID: 8527153
[TBL] [Abstract][Full Text] [Related]
14. Topical minoxidil for hair regrowth.
Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair Follicular Microenvironment and promote hair regeneration in androgenetic alopecia.
Yan A; Ruan R; Zhu X; Qiang W; Guan Y; Yu Q; Sun H; Liu M; Zhu H
Int J Pharm; 2023 Nov; 646():123498. PubMed ID: 37820942
[TBL] [Abstract][Full Text] [Related]
16. Use of topical minoxidil therapy for androgenetic alopecia in women.
Jacobs JP; Szpunar CA; Warner ML
Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
[TBL] [Abstract][Full Text] [Related]
17. Action of topical minoxidil in the bald stump-tailed macaque.
Uno H; Cappas A; Brigham P
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):657-68. PubMed ID: 3558911
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
19. The effect of topical minoxidil on hair follicular cycles of rats.
Mori O; Uno H
J Dermatol; 1990 May; 17(5):276-81. PubMed ID: 2380431
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α Stimulators Function Equally to Leading Hair Loss Agents in Enhancing Dermal Papilla Growth.
Bukowiecki J; Pförringer D; Thor D; Duscher D; Brett E
Skin Pharmacol Physiol; 2020; 33(6):309-316. PubMed ID: 33326985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
